Rotavirus Vaccine Caused Rotavirus Infection In Two Immune-Suppressed Babies Two infants receiving the first two of three scheduled doses of the live, attenuated-virus rotavirus vaccine (RotaTeq) developed infections traced to the product...
Read moreMolecular characterization of the first G24P[14] rotavirus strain detected in humans
Here we report the genome of a novel rotavirus A (RVA) strain detected in a stool sample collected during routine surveillance by the Centers for Disease Control and Prevention’s New Vaccine Surveillance Network. The strain...
Read moreDetection of Novel Rotavirus Strain by Vaccine Postlicensure Surveillance
urveillance for rotavirus-associated diarrhea after implementation of rotavirus vaccination can assess vaccine effectiveness and identify disease-associated genotypes. During active vaccine postlicensure surveillance in the United States, we...
Read moreSymptomatic Infection and Detection of Vaccine and Vaccine-Reassortant Rotavirus Strains in 5 Children: A Case Series
Vaccine Reasortment of Rotavirus – Vaccine Creating New Strains Vaccine or vaccine-reassortant rotavirus strains were detected in fecal specimens from 5 of 106 (4.7%) immunocompetent children who required treatment for rotavirus...
Read moreRotavirus vaccines in France : because of three infant death and too many serious side effects vaccines are no longer recommended for routine children immunization
Since the vaccination againts rotavirus is recommended by WHO in all the world and since it was already introduced in the vaccination schedule of many countries, I think safety information must be shared. In France two vaccines Rotarix ® from GSK...
Read moreTwo babies die in France after Rotavirus vaccinations
Health authorities in France are reviewing whether a common vaccine to prevent stomach illnesses should be given to babies, after it emerged this week that two newborns died following the inoculations. A report has been submitted to...
Read moreIndia to re-evaluate rotavirus vaccine
Delhi will be part of the Indian Government’s plan to study one lakh infants so as to re-evaluate the effect of its indigenous vaccine against rotavirus gastroenteritis which was released earlier this month. Also part of the study, which is...
Read moreComparison of virus shedding after lived attenuated and pentavalent reassortant rotavirus vaccine
Transmission of rotavirus vaccine or vaccine-reassortant strains to unvaccinated contacts has been reported. Therefore, it is essential to evaluate and characterize the nature of vaccine–virus shedding among rotavirus vaccine recipients. Two...
Read moreIdentification of Strains of Rotavirus Vaccine RotaTeq® in Infants with Gastroenteritis Following Routine Vaccination
Background RotaTeq was introduced into the Australian National Immunisation Program in 2007. This study identified and characterised rotavirus strains excreted by infants who presented with symptoms of gastroenteritis following recent RotaTeq...
Read moreRotavirus vaccine-derived shedding and viral reassortants
Two live, attenuated rotavirus vaccines, RotaTeq® (Merck) and Rotarix® (GlaxoSmithKline), have been used in Australia since July 2007 to prevent severe rotavirus gastroenteritis in children. Using active postvaccination monitoring, passive...
Read moreDetection of Rotateq Vaccine-Derived, Double-Reassortant Rotavirus in a 7-Year-Old Child with Acute Gastroenteritis
We describe a case of acute gastroenteritis in a schoolgirl associated with a detection of vaccine-derived, human-bovine double reassortant G1P[8] rotavirus, without any known contact with recently vaccinated infants. We propose that human-bovine...
Read moreVaccine-derived Human-bovine Double Reassortant Rotavirus in Infants With Acute Gastroenteritis
We describe 3 cases of acute gastroenteritis in healthy infants after vaccination with RotaTeq, shedding a G1P[8] human-bovine double reassortant rotavirus in stools. Such a double reassortant virus appears stable in vitro and may explain...
Read more